CH626360A5 - - Google Patents

Download PDF

Info

Publication number
CH626360A5
CH626360A5 CH1355376A CH1355376A CH626360A5 CH 626360 A5 CH626360 A5 CH 626360A5 CH 1355376 A CH1355376 A CH 1355376A CH 1355376 A CH1355376 A CH 1355376A CH 626360 A5 CH626360 A5 CH 626360A5
Authority
CH
Switzerland
Prior art keywords
phenyl
methoxybenzothiophene
preparation
reacted
hydrogen
Prior art date
Application number
CH1355376A
Other languages
German (de)
English (en)
Inventor
Charles David Jones
Tulio Suarez
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH626360A5 publication Critical patent/CH626360A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH1355376A 1975-10-28 1976-10-27 CH626360A5 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62600975A 1975-10-28 1975-10-28

Publications (1)

Publication Number Publication Date
CH626360A5 true CH626360A5 (cs) 1981-11-13

Family

ID=24508577

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1355376A CH626360A5 (cs) 1975-10-28 1976-10-27

Country Status (27)

Country Link
US (1) US4075227A (cs)
JP (1) JPS5253852A (cs)
AR (1) AR216451A1 (cs)
AT (1) AT352709B (cs)
AU (1) AU509682B2 (cs)
BE (1) BE847718A (cs)
BG (1) BG27554A3 (cs)
CA (1) CA1064031A (cs)
CH (1) CH626360A5 (cs)
CS (1) CS196328B2 (cs)
DD (1) DD127463A5 (cs)
DE (1) DE2647864C2 (cs)
DK (1) DK484576A (cs)
ES (1) ES452737A1 (cs)
FR (1) FR2329270A1 (cs)
GB (1) GB1572506A (cs)
GR (1) GR62400B (cs)
IE (1) IE43970B1 (cs)
IL (1) IL50413A (cs)
MX (1) MX3972E (cs)
NL (1) NL7611972A (cs)
NZ (1) NZ182428A (cs)
PL (1) PL109366B1 (cs)
PT (1) PT65753B (cs)
RO (1) RO70768A (cs)
SE (1) SE427035B (cs)
ZA (1) ZA766442B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
US4436748A (en) * 1980-10-20 1984-03-13 Hoechst-Roussel Pharmaceuticals Inc. Benzo[b]thiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4528399A (en) * 1981-04-22 1985-07-09 Hoechst-Roussel Pharmaceuticals Inc. Benzo[b]thiophenes intermediates
US5354861A (en) * 1992-11-04 1994-10-11 National University Of Singapore 2-(benzyl)-3-arylbenzofurans as antitumour and hypocholesterolemic agents
IL109990A (en) * 1993-06-21 1999-06-20 Lilly Co Eli Materials and methods for screening anti-osteoporosis agents
US5523416A (en) * 1994-07-22 1996-06-04 Eli Lilly And Company Process for preparing 3-(4-aminoethoxy-benzoyl) benzo (B)-thiophenes
US5552401A (en) * 1995-02-28 1996-09-03 Eli Lilly And Company 2-benzyl-3-arylbenzothiophenes
ZA9710262B (en) * 1996-11-19 1999-05-13 Lilly Co Eli Process for the synthesis of benzothiophenes
US6107346A (en) * 1997-08-11 2000-08-22 Eli Lilly And Company Methods for treating hyperlipidemia
US5908859A (en) * 1997-08-11 1999-06-01 Eli Lilly And Company Benzothiophenes for inhibiting hyperlipidemia
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
CN1193986C (zh) * 1999-10-04 2005-03-23 日本曹达株式会社 苯酚化合物和使用它的记录材料
AU2002230409A1 (en) * 2000-11-27 2002-06-03 Eli Lilly And Company Process for preparing 3-aryl-benzo(b)thiophenes
AUPR283801A0 (en) * 2001-02-01 2001-03-01 Australian National University, The Chemical compounds and methods
JP3904517B2 (ja) * 2001-04-04 2007-04-11 日本曹達株式会社 組成物、記録材料及び記録シート
EP1395563B1 (en) * 2001-05-22 2006-03-29 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
EP1401446B1 (en) * 2001-05-22 2005-02-09 Eli Lilly And Company Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
DE10309645A1 (de) 2003-03-06 2004-09-16 Basf Ag Verfahren zur Herstellung von a-(3-Arylthio)-acetophenonen
KR20190117582A (ko) 2017-02-10 2019-10-16 쥐원 쎄라퓨틱스, 인크. 벤조티오펜 에스트로겐 수용체 조정제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1456323A (en) * 1974-06-06 1976-11-24 Labaz Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
US3947470A (en) * 1974-06-20 1976-03-30 Smithkline Corporation Substituted benzofurans and benzothiophenes
US4001426A (en) * 1974-10-17 1977-01-04 Smithkline Corporation Substituted benzofurans and benzothiophenes
US3983245A (en) * 1975-02-06 1976-09-28 Smithkline Corporation Certain 4-(3-azacycloalkoxy or azacycloalkylmethoxy)benzoylbenzofurans or benzothiophenes

Also Published As

Publication number Publication date
CS196328B2 (en) 1980-03-31
PL109366B1 (en) 1980-05-31
ATA800776A (de) 1979-03-15
BG27554A3 (en) 1979-11-12
AU1740876A (en) 1978-03-09
ES452737A1 (es) 1978-01-01
DD127463A5 (cs) 1977-09-28
AU509682B2 (en) 1980-05-22
CA1064031A (en) 1979-10-09
RO70768A (ro) 1982-10-26
GR62400B (en) 1979-04-10
IE43970L (en) 1977-04-28
SE427035B (sv) 1983-02-28
JPS61344B2 (cs) 1986-01-08
NL7611972A (nl) 1977-05-02
DE2647864A1 (de) 1977-05-12
FR2329270B1 (cs) 1979-07-27
IE43970B1 (en) 1981-07-15
GB1572506A (en) 1980-07-30
DK484576A (da) 1977-04-29
US4075227A (en) 1978-02-21
IL50413A (en) 1980-05-30
PT65753A (en) 1976-11-01
AT352709B (de) 1979-10-10
ZA766442B (en) 1978-06-28
AR216451A1 (es) 1979-12-28
NZ182428A (en) 1978-11-13
SE7611954L (sv) 1977-04-29
FR2329270A1 (fr) 1977-05-27
DE2647864C2 (de) 1985-04-25
JPS5253852A (en) 1977-04-30
PT65753B (en) 1978-04-20
BE847718A (fr) 1977-04-28
MX3972E (es) 1981-10-20
IL50413A0 (en) 1976-11-30

Similar Documents

Publication Publication Date Title
DE2647907C2 (de) 2-Phenyl-3-aroylbenzothiophene und Verfahren zu ihrer Herstellung
DE2647864C2 (de) 2-Aroyl-3-phenylbenzothiophenverbindungen und Verfahren zu ihrer Herstellung
EP0004279B1 (de) Verfahren zur Herstellung von 4-Pyridon-3-carbonsäuren, 1-Cyclopropyl-4-Pyridon-3-Carbonsäurederivate und diese enthaltende Arzneimittel
DE2165260A1 (de) Verfahren zur Herstellung von N-substituierten Dibenzo eckige Klammer auf b,f eckige Klammer zu thiepin-10-methylaminen und zugehörige neue Zwischenprodukte
DE1695836A1 (de) Substituierte Piperidinoalkylthianaphthene und -benzofurane
CH626045A5 (cs)
CH642077A5 (de) 3-fluor-10-piperazino-8-substituierte 10,11-dihydrodibenzo-(b,f)-thiepine, deren saeureadditionssalze, verfahren zur herstellung derselben und diese enthaltende zubereitungen.
DE1618465C3 (de) Phenylessigsäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2647906C2 (de) Aroylphenylindene und Aroylphenylnaphthaline und -hydronaphthaline sowie Verfahren zu ihrer Herstellung
DE1816845A1 (de) 2-Cycloalkyl-1-phenyldihydronaphthaline und -tetrahydronaphthaline sowie Verfahren zur Herstellung derselben
DE2645865C2 (cs)
DE1493855C3 (de) 1- eckige Klammer auf p-(Dialkylaminoalkoxy)-phenyl eckige Klammer zu -i-phenyl-2-phenyl-n-alkane und Verfahren zu deren Herstellung
DE1695963A1 (de) Cycloalkenamin-p-benzochinonaddukte und Verfahren zu ihrer Herstellung
DE1695962A1 (de) (2-Aminocycloalkyl)hydrochinone und Derivate derselben sowie Verfahren zu ihrer Herstellung
CH624398A5 (en) Process for the preparation of aroylphenylnaphthalenes
DE1670386A1 (de) Neue Cyclohexanderivate und Verfahren zu ihrer Herstellung
DE1942521A1 (de) Cyclopropancarbonsaeurederivate und Verfahren zu deren Herstellung
DE2448454C2 (de) 1-Oxo-5-indanyloxyalkylcarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3641907A1 (de) 4h-benzo(4,5)cyclohepta(1,2-b)thiophen derivate
DE2151487A1 (de) Pharmazeutische Massen
DE1568848B2 (de) Trans-Isomere von Alkenderivaten und Verfahren zu ihrer Herstellung
AT244327B (de) Verfahren zur Herstellung von Diphenylalkylaminen und ihren physiologisch verträglichen Salzen
AT367030B (de) Verfahren zur herstellung von neuen benzoesaeure- derivaten und deren estern und salzen
AT359479B (de) Verfahren zur herstellung von neuen benzoe- saeuren und deren estern und salzen
DE3217446A1 (de) Substituierte thiocarbamoyl-thenoylacetonitrile, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased